Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SQI Diagnostics Submits RALI-Dx™ IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization

prnewswireApril 02, 2021

Tag: COVID-19 , SQI , RALI-Dx™ IL-6

PharmaSources Customer Service